Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Annals of the New York Academy of Sciences|March 16, 2007
Emergence of human angiohematopoietic cells in normal development and from cultured embryonic stem cellsElias T Zambidis, Lidia Sinka, Manuela Tavian, et al.
Stem Cells International|October 1, 2016
High-Fidelity Reprogrammed Human IPSCs Have a High Efficacy of DNA Repair and Resemble hESCs in Their MYC Transcriptional SignaturePratik K Nagaria, Carine Robert, Tea Soon Park, et al.
Blood|August 30, 2008
Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cellsElias T Zambidis, Tea Soon Park, Wayne Yu, et al.
Stem Cells International|September 12, 2013
Cellular kinetics of perivascular MSC precursorsWilliam C W Chen, Tea Soon Park, Iain R Murray, et al.
Stem Cells Translational Medicine|March 3, 2021
Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1Manasa P Srikanth, Jace W Jones, Maureen Kane, et al.
STAR Protocols|January 14, 2024
Differentiation of monocytes and polarized M1/M2 macrophages from human induced pluripotent stem cellsTea Soon Park, Rishabh Hirday, Russell Quinn, et al.
Plos One|August 21, 2012
Growth factor-activated stem cell circuits and stromal signals cooperatively accelerate non-integrated iPSC reprogramming of human myeloid progenitorsTea Soon Park, Jeffrey S Huo, Ann Peters, et al.
Stem Cells and Development|October 7, 2010
Placental perivascular cells for human muscle regenerationTea Soon Park, Manuela Gavina, Chien-Wen Chen, et al.
Stem Cells (Dayton, Ohio)|May 8, 2014
Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic developmentLeelamma M Panicker, Diana Miller, Ola Awad, et al.
The International Journal of Developmental Biology|June 22, 2010
Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cellsAnn Peters, Paul W Burridge, Marina V Pryzhkova, et al.
Pageof 4